Functional CD4 T cells after intercellular molecular transfer of OX40 ligand

被引:56
作者
Baba, E
Takahashi, Y
Lichtenfeld, J
Tanaka, R
Yoshida, A
Sugamura, K
Yamamoto, N
Tanaka, Y
机构
[1] Univ Ryukyus, Fac Med, Dept Immunol & Infect Dis, Okinawa Asia Res Ctr Med Sci, Okinawa, Japan
[2] Tokyo Med & Dent Univ, Sch Med, Dept Microbiol, Tokyo 113, Japan
[3] Tohoku Univ, Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan
关键词
D O I
10.4049/jimmunol.167.2.875
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OX40/OX40 ligand (OX40L) proteins play critical roles in the T cell-B cell and T cell-dendritic cell interactions. Here we describe the intercellular transfer of OX40L molecules by a non-Ag specific manner. After 2-h coculture of activated CD4(+) T cell (OX40L(-), OX40(+)) with FLAG peptide-tagged OX40L (OX40L-flag) protein-expressing COS-1 cells, the OX40L-flag protein was detected on the cell surface of the CD4(+) T cells by both anti-OX40L and anti-FLAG mAbs. The intercellular OX40L transfer was specifically abrogated by pretreatment of the COS-1 cells with anti-OX40L mAb, 5A8. The OX40L transfer to OX40-negative cells was also observed, indicating an OX40-independent pathway of OX40L transfer. HUVECs, allostimulated monocytes, and human T cell leukemia virus type I-infected T cells, which all express OX40L, can potentially act as the donor cells of OX40L. The entire molecule of OX40L was transferred and stabilized on the recipient cell membrane with discrete punctate formation. The transferred OX40L on normal CD4(+) T cells was functionally active as they stimulated latent HIV-1-infected cells to produce viral proteins via OX40 signaling. Therefore, these findings suggest that the intercellular molecular transfer of functional OX40L may be involved in modifying the immune responses.
引用
收藏
页码:875 / 882
页数:8
相关论文
共 25 条
  • [1] MOLECULAR CHARACTERIZATION OF MURINE AND HUMAN OX40/OX40 LIGAND SYSTEMS - IDENTIFICATION OF A HUMAN OX40 LIGAND AS THE HTLV-1-REGULATED PROTEIN GP34
    BAUM, PR
    GAYLE, RB
    RAMSDELL, F
    SRINIVASAN, S
    SORENSEN, RA
    WATSON, ML
    SELDIN, MF
    BAKER, E
    SUTHERLAND, GR
    CLIFFORD, KN
    ALDERSON, MR
    GOODWIN, RG
    FANSLOW, WC
    [J]. EMBO JOURNAL, 1994, 13 (17) : 3992 - 4001
  • [2] A two-step, two-signal model for the primary activation of precursor helper T cells
    Bretscher, PA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (01) : 185 - 190
  • [3] Brocker T, 1999, EUR J IMMUNOL, V29, P1610, DOI 10.1002/(SICI)1521-4141(199905)29:05<1610::AID-IMMU1610>3.0.CO
  • [4] 2-8
  • [5] Requirements for peptide-induced T cell receptor downregulation on naive CD8(+) T cells
    Cai, ZL
    Kishimoto, H
    Brunmark, A
    Jackson, MR
    Peterson, PA
    Sprent, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (04) : 641 - 651
  • [6] CALDERHEAD DM, 1993, J IMMUNOL, V151, P5261
  • [7] The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells
    Davis, DM
    Mandelboim, O
    Luque, I
    Baba, E
    Boyson, J
    Strominger, JL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (08) : 1265 - 1274
  • [8] A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts
    Dustin, ML
    Olszowy, MW
    Holdorf, AD
    Li, J
    Bromley, S
    Desai, N
    Widder, P
    Rosenberger, F
    van der Merwe, PA
    Allen, PM
    Shaw, AS
    [J]. CELL, 1998, 94 (05) : 667 - 677
  • [9] CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1
    Flynn, S
    Toellner, KM
    Raykundalia, C
    Goodall, M
    Lane, P
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (02) : 297 - 304
  • [10] IDENTIFICATION OF A HUMAN OX-40 LIGAND, A COSTIMULATOR OF CD4+ T-CELLS WITH HOMOLOGY TO TUMOR-NECROSIS-FACTOR
    GODFREY, WR
    FAGNONI, FF
    HARARA, MA
    BUCK, D
    ENGLEMAN, EG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (02) : 757 - 762